BMEA - Biomea Fusion, Inc.

QQQ $ 592.40 $ 0.00 (0 %)

DIA $ 456.07 $ 0.00 (0 %)

SPY $ 653.89 $ 0.00 (0 %)

TLT $ 91.57 $ 0.00 (0 %)

GLD $ 398.72 $ 0.00 (0 %)

Previous Close

$ 1.59

Open

$ 1.65

Bid

$ 1.59 x 24,804

Ask

$ 1.70 x 25

Day's Range

-- - --

52 Week Range

$ 1.29 - $ 12.85

Volume

1,341,154

Average Volume

Market Cap

94.62M

Beta (5Y Monthly)

$ 0.49

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-05-2025	06-30-2025	10-Q
2	05-05-2025	03-31-2025	10-Q
3	03-31-2025	12-31-2024	10-K
4	10-29-2024	09-30-2024	10-Q
5	07-31-2024	06-30-2024	10-Q
6	05-02-2024	03-31-2024	10-Q
7	03-28-2024	12-31-2023	10-K
8	10-30-2023	09-30-2023	10-Q
9	07-31-2023	06-30-2023	10-Q
10	05-02-2023	03-31-2023	10-Q
11	03-28-2023	12-31-2022	10-K
12	11-07-2022	09-30-2022	10-Q
13	08-01-2022	06-30-2022	10-Q
14	05-16-2022	03-31-2022	10-Q
15	02-28-2022	12-31-2021	10-K
16	11-03-2021	09-30-2021	10-Q
17	08-11-2021	06-30-2021	10-Q
18	05-27-2021	03-31-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12 Health Care Stocks Moving In Tuesday's ...
10/07/2025 17:06:17

nasdaq-tumbles-200-points-trilogy-metals-shares-spike-higher

Nasdaq Tumbles 200 Points; Trilogy Metals ...
10/07/2025 16:29:00

biomea-fusion-stock-plummets-following-public-offering-diabetes-study

Biomea Fusion Stock Plummets Following Pub...
10/07/2025 14:35:35

Biomea Fusion reported favorable safety for icovamenib in a 52-week diabetes study, alongside a $25 million public offering.

dow-jumps-over-100-points-mccormick-earnings-top-views

Dow Jumps Over 100 Points; McCormick Earni...
10/07/2025 14:20:36

12 Health Care Stocks Moving In Tuesday's ...
10/07/2025 12:08:21

Biomea Fusion Announces Pricing Of Its Und...
10/07/2025 12:05:48

Biomea Fusion, Inc. ("Biomea") (NASDAQ:BMEA), a clinical-stage diabetes and obesity company, today announced the pricin...

12 Health Care Stocks Moving In Monday's A...
10/06/2025 21:06:27

Biomea Fusion Announces Proposed Public Of...
10/06/2025 20:18:41

Biomea Fusion, Inc. ("Biomea") (NASDAQ:BMEA), a clinical-stage diabetes and obesity company, announced today that it ha...

Biomea Fusion Announces 52-Week Phase II D...
10/06/2025 20:04:28

Icovamenib showed a sustained treatment benefit at Week 52 (9 months past the end of treatment) in the severe insulin-deficient...

D. Boral Capital Maintains Buy on Biomea F...
10/03/2025 12:32:26

D. Boral Capital analyst Jason Kolbert maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and maintains $16 price target.

Biomea Fusion Presents Data Showing Icovam...
09/16/2025 11:17:19

this-oddity-tech-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday

This Oddity Tech Analyst Begins Coverage O...
08/28/2025 12:43:21

Jefferies Initiates Coverage On Biomea Fus...
08/28/2025 12:31:06

Jefferies analyst Roger Song initiates coverage on Biomea Fusion (NASDAQ:BMEA) with a Buy rating and announces Price Target ...

Citigroup Maintains Buy on Biomea Fusion, ...
08/11/2025 13:13:35

Citigroup analyst Yigal Nochomovitz maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and lowers the price target from $9 to $7.

Scotiabank Maintains Sector Outperform on ...
08/06/2025 16:27:44

Scotiabank analyst George Farmer maintains Biomea Fusion (NASDAQ:BMEA) with a Sector Outperform and lowers the price target ...

D. Boral Capital Maintains Buy on Biomea F...
08/06/2025 13:11:47

D. Boral Capital analyst Jason Kolbert maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and maintains $16 price target.

Biomea Fusion Q2 EPS $(0.51) Beats $(0.54)...
08/05/2025 20:36:40

Biomea Fusion (NASDAQ:BMEA) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.54)...

D. Boral Capital Maintains Buy on Biomea F...
07/21/2025 17:27:05

D. Boral Capital analyst Jason Kolbert maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and maintains $16 price target.

Citigroup Maintains Buy on Biomea Fusion, ...
07/16/2025 14:44:20

Citigroup analyst Yigal Nochomovitz maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and lowers the price target from $22 to...

D. Boral Capital Maintains Buy on Biomea F...
06/24/2025 12:15:52

D. Boral Capital analyst Jason Kolbert maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and maintains $16 price target.